Physician profile
Patrick Dewey Webb
NPI 1851447668
$1,440.18
in general payments reported to CMS, 2019-2025
17 companies · $293 in 2025
The $293 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $109 · 2021: $14.32 · 2022: $79.26 · 2023: $260 · 2024: $186 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $739.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $424.31 | 2019-2025 | |
| Abbvie INC. | $225.25 | 2019-2025 | Rinvoq |
| Janssen Biotech, INC. | $167.93 | 2019-2025 | Stelara, Tremfya |
| Pfizer INC. | $149.55 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $109.03 | 2019-2025 | Xifaxan |
| Celgene Corporation | $73.82 | 2021-2023 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $71.34 | 2019-2025 | Entyvio |
| Regeneron Healthcare Solutions, INC. | $49.23 | 2023-2025 | Dupixent |
| Qol Medical, LLC | $31.45 | 2020 | |
| Ethicon US, LLC | $24.21 | 2020 | |
| Ardelyx, INC. | $22.78 | 2023 | Ibsrela |
| Amgen INC. | $20.42 | 2025 | |
| Organon LLC | $18.04 | 2023 | Hadlima, Renflexis |
| Shionogi INC | $14.72 | 2019 | |
| Merck Sharp & Dohme LLC | $13.41 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $12.72 | 2019 | |
| Shire North American Group INC | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.